Economic development - LyonbiopôleLyonbiopôle, pôle de compétitivité mondial en santé

Economic development

Headlines

New studies confirm anti-CD160 antibodies are potential therapeutics for ophthalmic diseases

July 2^nd, 2018

THERANEXUS ANNOUNCES GERMAN AUTHORITIES APPROVAL FOR ITS PHASE 2 CLINICAL TRIAL

June 27^th, 2018

Synthelis and MAbSilico sign a commercial agreement

June 27^th, 2018

Diary

Aging Skin Day

September 25^th, 2018

Collaborative Day

October 18^th, 2018

Calls for projects

SME Instrument (phase 1)

Before September 5^th, 2018

Eurostars calls

Before September 13^th, 2018

SME Instrument (phase 2)

Before October 10^th, 2018

All calls for projects

Contact

Bâtiment Domilyon - 321, avenue Jean Jaurès - 69007 Lyon

Tel. : 04.72.76.53.30 - Fax : 09.55.91.30.26

info@lyonbiopole.com

By continuing to browse our site you agree to our use of cookies, revised Privacy Policy and Terms of Service. More information... Close